PEDRONI, Monica
 Distribuzione geografica
Continente #
NA - Nord America 17.490
AS - Asia 7.093
EU - Europa 6.246
SA - Sud America 1.010
AF - Africa 141
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 5
Totale 31.996
Nazione #
US - Stati Uniti d'America 17.287
SG - Singapore 2.718
GB - Regno Unito 2.640
CN - Cina 1.760
HK - Hong Kong 825
BR - Brasile 785
VN - Vietnam 699
SE - Svezia 660
IT - Italia 656
DE - Germania 628
UA - Ucraina 355
FI - Finlandia 326
RU - Federazione Russa 293
TR - Turchia 235
FR - Francia 227
KR - Corea 161
IN - India 138
BG - Bulgaria 130
BD - Bangladesh 94
CA - Canada 87
AR - Argentina 79
IQ - Iraq 72
MX - Messico 72
ID - Indonesia 65
BE - Belgio 56
NL - Olanda 55
JP - Giappone 53
ZA - Sudafrica 45
IE - Irlanda 43
AE - Emirati Arabi Uniti 38
EC - Ecuador 38
CO - Colombia 31
MY - Malesia 29
ES - Italia 28
PK - Pakistan 27
UZ - Uzbekistan 27
PL - Polonia 25
VE - Venezuela 25
PH - Filippine 22
CL - Cile 21
AT - Austria 20
MA - Marocco 17
NP - Nepal 17
CZ - Repubblica Ceca 15
KE - Kenya 14
LT - Lituania 14
TN - Tunisia 14
DZ - Algeria 13
EG - Egitto 13
JO - Giordania 13
TH - Thailandia 11
SA - Arabia Saudita 10
KZ - Kazakistan 9
LV - Lettonia 9
PE - Perù 9
TW - Taiwan 9
UY - Uruguay 9
AU - Australia 8
AZ - Azerbaigian 8
CH - Svizzera 8
IL - Israele 8
BO - Bolivia 7
CR - Costa Rica 7
DO - Repubblica Dominicana 7
JM - Giamaica 7
PA - Panama 7
PR - Porto Rico 7
PT - Portogallo 7
SY - Repubblica araba siriana 7
AL - Albania 6
ET - Etiopia 6
KG - Kirghizistan 6
RO - Romania 6
IR - Iran 5
PS - Palestinian Territory 5
AO - Angola 4
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
LK - Sri Lanka 4
NO - Norvegia 4
OM - Oman 4
PY - Paraguay 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BY - Bielorussia 3
DK - Danimarca 3
GT - Guatemala 3
LB - Libano 3
NZ - Nuova Zelanda 3
QA - Qatar 3
RS - Serbia 3
SI - Slovenia 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
EU - Europa 2
GR - Grecia 2
ML - Mali 2
MT - Malta 2
NI - Nicaragua 2
Totale 31.970
Città #
Southend 2.004
Singapore 1.829
Santa Clara 1.476
Ashburn 1.453
Fairfield 1.438
Woodbridge 1.005
Hong Kong 813
Houston 769
Chandler 768
Chicago 762
Jacksonville 678
Ann Arbor 594
Wilmington 565
Seattle 558
San Jose 542
Dearborn 502
Los Angeles 486
Cambridge 482
Hefei 456
Nyköping 413
Beijing 360
Salt Lake City 309
London 305
Ho Chi Minh City 214
Helsinki 190
Hanoi 185
The Dalles 174
Modena 167
Tampa 155
Seoul 150
New York 144
Elk Grove Village 143
San Diego 138
Council Bluffs 137
Princeton 137
Izmir 126
Sofia 126
Eugene 120
Bremen 104
Lauterbourg 101
Dallas 89
Shanghai 87
Lancaster 85
Munich 82
Buffalo 78
Moscow 74
Frankfurt am Main 73
Sterling 70
São Paulo 67
Milan 63
Columbus 61
Miami 55
Des Moines 54
Orem 54
Fremont 49
Da Nang 44
Brussels 42
Detroit 42
Dublin 42
Dulles 42
Tokyo 42
Jakarta 37
Phoenix 36
Falls Church 35
Atlanta 31
Rio de Janeiro 31
Haiphong 29
Boardman 28
Rome 27
Baghdad 26
Mexico City 26
Nanjing 26
Turku 26
Chennai 25
Guangzhou 25
Tashkent 25
Pittsburgh 23
Dhaka 22
Kunming 22
Montreal 22
Brooklyn 21
Hounslow 21
Ottawa 21
Kansas City 20
Belo Horizonte 19
Norwalk 19
Warsaw 19
Denver 18
Jersey City 18
Quito 18
Toronto 18
Grafing 17
San Francisco 17
Curitiba 16
Philadelphia 16
Changsha 15
Nuremberg 15
Amsterdam 14
Jinan 14
Kent 14
Totale 23.245
Nome #
Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations. 443
Relationship between MUC5AC and altered expression of MLH1 protein in mucinous and non-mucinous colorectal carcinomas 439
Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes 436
BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-asociated polyposis pedigrees 425
Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. 421
K-ras and p53 mutations in hereditary non-polyposis colorectal cancers 406
Value of MLH1 and MSH2 mutations in the appearance of Muir-Torre syndrome phenotype in HNPCC patients presenting sebaceous gland tumors or Keratoacanthomas 406
Attenuated polyposis of the large bowel: a morphologic and molecular approach 400
Different phenotypes in Muir-Torre Syndrome: clinical and biomolecular characterization in two italian families 387
Autophagy is upregulated during colorectal carcinogenesis, and in DNA microsatellite stable carcinomas 383
Microsatellite instability in multiple colorectal tumors 380
Molecular features and methylation status in early onset (< 40 years) colorectal cancer: a population based, case-control study 376
Aetiology of colorectal cancer and relevance of monogenic inheritance. 367
Incidence, clinical features and possible etiology of early onset (≤40 years) colorectal neoplasms. 367
Molecular screening for Hereditary Non Polyposis Colorectal Cancer (HNPCC): a prospective, population-based study 364
Aberrant crypt foci in colorectal carcinogenesis. Cell and crypt dynamics 364
Aberrant crypt foci in patients with colorectal cancer 361
Analysis of telomere dynamics in peripheral blood cells from patients with Lynch syndrome 361
Incidence and survival of patients with Dukes' A (stages T1 and T2) colorectal carcinoma: a 15-year population-based study. 358
Argyrophilic nucleolar organizer regions and bromodeoxyuridine and h3-thymidine labelling indices in colorectal cancer 356
An unusual case of familial adenomatous polyposis with very early symptom occurrence 354
Staging and survival of colorectal cancer: are we making progress? The 14-year experience of a Specialized cancer Registry 354
Frequency of constitutional MSH6 mutations in a consecutive series of families with clinical suspicion of HNPCC. 349
Double heterozygosity for BRCA1 and hMLH1 gene mutations in a 46-year-old woman with five primary tumors 345
Frequency and clinical features of multiple tumors of the large bowel in the general population and in patients with hereditary colorectal carcinoma 337
A mononucleotide markers panel to identify hMLH1/hMSH2 germline mutations 337
Immunohistochemical expression of MYH protein can be used to identify patients with MYH-associated polyposis 336
Histology of aberrant crypt foci in the human colon 332
Genomic instability and target gene mutations in colon cancers with different degrees of allelic shifts 329
Relative role of APC and MUTYH mutations in the pathogenesis of familial adenomatous polyposis. 328
Attenuated adenomatous polyposis of the large bowel: Present and future 320
Application of a 5-tiered scheme for standardized classification of 2,360 unique mismatch repair gene variants in the InSiGHT locus-specific database 319
Th Inducing POZ-Kruppel Factor (ThPOK) Is a Key Regulator of the Immune Response since the Early Steps of Colorectal Carcinogenesis 319
Small bowel carcinoma in hereditary nonpolyposis colorectal cancer 318
Epidemiology of colorectal cancer: the 21-year experience of a specialised registry. 315
Problems in the identification of hereditary nonpolyposis colorectal cancer in two families with late development of full-blown clinical spectrum 314
Identification of Muir-Torre Syndrome among patients with sebaceous tumors and keratoacanthomas: role of clinical features, microsatellite instability and immunohistochemistry 314
Clinical outcome of low- and high-risk malignant colorectal polyps: results of a population-based study and meta-analysis of the available literature 311
Biologic characterization of Hereditary Non-Polyposis Colorectal Cancer. Nuclear ploidy, AgNOR count, microvessel distribution, oncogene expression, and grade-related parameters. 304
Aberrant DNA methylation profiles of inherited and sporadic colorectal cancer 301
Myeloperoxidase-positive cell infiltration of normal colorectal mucosa is related to body fatness and is predictive of adenoma occurrence 299
Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer. 296
Microsatellite instability and colorectal cancer prognosis. 294
Lymph node evaluation in stage IIA colorectal cancer and its impact on patient prognosis: A population-based study 292
Clinical features, frequency and prognosis of Dukes' a colorectal carcinoma: A population-based investigation 292
Investigation of APC mutations in a Turkish familial adenomatous polyposis family by heterodublex analysis 290
Hereditary colorectal cancer in the general population: from cancer registration to molecular diagnosis 287
Prognostic relevance of microsatellite instability in pT3N0M0 colon cancer: a population-based study 284
Clinical and molecular diagnosis of hereditary non-polyposis colorectal cancer: problems and pitfalls in an extended pedigree 283
Prognostic significance of histological features and biological parameters in stage I (pT1 and pT2) colorectal adenocarcinoma 282
Evaluation of the replication error phenotype in relation to molecular and clinicopathological features in hereditary and early onset colorectal cancer. 281
Clinical and molecular features of attenuated adenomatous polyposis in northern Italy. 280
Characterization of MLH1 and MSH2 alternative splicing and its relevance to molecular testing of colorectal cancer susceptibility. 272
A founder MLH1 mutation in families from the districts of Modena and Reggio-Emilia in northern Italy with hereditary non-polyposis colorectal cancer associated with protein elongation and instability. 271
Risk of colorectal polyps and of malignancies in asymptomatic carriers of mutations in the main DNA mismatch repair genes 271
Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry. 270
Colorectal carcinoma in different age groups: A population based investigation 269
A case of pneumatosis cystoides intestinalis mimicking familial adenomatous polyposis 268
Risk of cancer revealed by follow-up of families with hereditary non-polyposis colorectal cancer: a population-based study 265
Analysis of mismatch repair gene mutations in Turkish HNPCC patients. 265
I tumori in Italia. Rapporto 2011: La sopravvivenza dei pazienti oncologici in Italia 265
Alternative marker panel for microsatellite instability analysis in detection of constitutional MLH1 and MSH2 mutations. 264
Diagnosis of hereditary non-polyposis colorectal cancer (HNPCC) [2] (multiple letters) 263
O6-methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis 262
Genetic testing among high-risk individuals in families with hereditary non polyposis colorectal cancer 258
L'immunoistochimica delle proteine del mismatch repair può essere un utile test per identificare i pazienti HNPCC? 257
Biological characterization of mucinous carcinoma of the colon and rectum 256
Incidence trend of malignant polyps through the data of a specialized colorectal cancer registry: clinical features and effect of screening. 254
Clinical and biologic heterogeneity of Hereditary NonPolyposis Colorectal Cancer. 250
Overweight, inflammation of normal colorectal mucosa, and cancer risk 244
MLH1 constitutional and somatic methylation in patients with MLH1 negative tumors fulfilling the revised Bethesda criteria 243
Epidemiologic and genetic factor in colorectal cancer: development of cancer in dizygotic twins in a family with Lynch syndrome 238
Alternative marker panel for Microsatellite Instability analysis in deection of contitutional MLH1 and MSH2 mutations. 237
Massive juvenile polyposis of the stomach in a family with SMAD4 gene mutation 237
Lack of PMS2 gene-truncating mutations in patients with hereditary colorectal cancer 236
Increased expression of autophagy-related proteins in human colorectal cancer development, and correlation with DNA Microsatellite Stable and Unstable 235
Prognostic relevance of MLH1 and MSH2 mutations in hereditary non-polyposis colorectal cancer patients. 234
[Italian cancer figures, report 2010: Cancer prevalence in Italy. Patients living with cancer, long-term survivors and cured patients] 228
Tumour spectrum in hereditary non-polyposis colorectal cancer (HNPCC) and in families with "suspected HNPCC". A population-based study in Northern Italy. Colorectal Cancer Study Group. 226
Duodenal carcinoma in a 37-year-old man with Cowden/Bannayan syndrome. 225
Clinical and molecular characterization of colorectal cancer in young Moroccan patients 224
Italian cancer figures, report 2013: Multiple tumours 221
Induction of altered cellular response to oxydative stress in HT29 colon cancer cells treated with metformin 221
Automated capture-based NGS workflow: one thousand patients experience in a clinical routine framework 218
Il registro dei tumori colorettali 213
Microsatellite instability and prognosis of colorectal cancer 209
Genotype-phenotype correlations in individuals with a founder mutation in the MLH1 gene and hereditary non-polyposis colorectal cancer 204
Cell kinetics evaluation of colorectal tumours after in vivo administration of bromodeoxyuridine 203
HMSH6 immunohistochemistry in patients with clinical suspicion of Hereditary Non-Polyposis Colorectal Cancer. 201
Epidemiology of cancer of the large bowel - The 12-year experience of a specialized registry in Northern Italy 197
MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events 196
Caratterizzazione immunoistochimica e biomolecolare del carcinoma colorettale giovanile 195
Expression of Autophagic and Inflammatory Markers in Normal Mucosa of Individuals with Colorectal Adenomas: A Cross Sectional Study among Italian Outpatients Undergoing Colonoscopy 194
MSH3 protein expression and nodal status in MLH1-deficient colorectal cancers. 188
Epidemiologia dei tumori del colon-retto. Incidenza, mortalità, familiarità e sopravvivenza nella ex USL di Modena, 1984-1998. 186
Microsatellite instability and mismatch-repair protein expression in hereditary and sporadic colorectal carcinogenesis 186
The role of hPMS1 and hPMS2 in predisposing to colorectal cancer 186
Hereditary nonpolyposis colorectal cancer: an approach to the selection of candidates to genetic testing based on clinical and molecular characteristics 180
Identification and biomolecular characterization of Muir-Torre Syndrome 174
Scanning electron microscopy of aberrant crypt foci in human colorectal mucosa 172
Totale 28.827
Categoria #
all - tutte 126.302
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 126.302


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021242 0 0 0 0 0 0 0 0 0 0 125 117
2021/20222.332 102 309 201 146 37 111 152 83 229 181 527 254
2022/20232.136 270 252 163 208 289 326 38 189 235 21 74 71
2023/20241.327 47 68 90 86 340 155 135 165 27 12 62 140
2024/20255.084 156 51 83 346 1.069 785 442 311 536 161 496 648
2025/202611.062 615 332 737 1.749 3.386 642 1.224 480 883 837 177 0
Totale 32.128